Cardiologist on the Over-Prescribing of Statins for Heart Disease
Understanding Cholesterol and Heart Disease
In this section, the speaker discusses the association between cholesterol and heart disease, as well as how statins work to lower cholesterol.
The Association Between Cholesterol and Heart Disease
- The association of high cholesterol with heart disease came from the Framingham study in Massachusetts.
- Total cholesterol is not a good indicator of heart disease risk. Most of your cholesterol is genetic, and people with genetically low cholesterol tend to not develop premature heart disease.
- Once you hit 50, as your cholesterol drops in Framingham, your mortality rate increases.
How Statins Work to Lower Cholesterol
- LDL bad cholesterol has no value in isolation in predicting heart disease.
- Randomized control trial data shows that there is no clear correlation between lowering LDL cholesterol and preventing heart attacks and strokes.
Statins: Are the Benefits Overstated?
In this section, Dr. Aseem Malhotra discusses the benefits of statins in preventing heart attacks and strokes.
Benefits of Statins
- Statins have anti-inflammatory and anti-clotting benefits.
- The real benefit in preventing heart attacks and strokes is through these mechanisms.
- The benefits are about 1% if you're low risk of heart disease.
- If you've had a heart attack, the benefit of a statin is 1 in 83 for saving your life and 1 in 39 for preventing a further heart attack over a five-year period.
Prescribing Statins After Heart Attacks
In this section, Dr. Aseem Malhotra talks about prescribing statins after heart attacks.
Prescribing Statins
- Many patients who have had heart attacks are automatically put on statins.
- Cardiologists read even checked their cholesterol because in the Cardiology Community they kind of knew that was like it doesn't matter what your cholesterol is let's put them on a Statin because the trials show there are benefits.
- Patients should be informed about the benefits before taking statins to avoid an exaggerated fear of stopping or an illusion of protection.
Absolute Terms
In this section, Dr. Aseem Malhotra explains the absolute terms when breaking down the benefits of statins.
Breaking Down Benefits
- When breaking down the benefits in absolute terms, it's important to note that best case scenario your benefit of a Statin is 1 in 83 for saving your life right and 1 in 39 and preventing a further heart attack over a five-year period.
- People find these numbers underwhelming.
Statin Benefits in Populations
In this section, Dr. Aseem Malhotra talks about the benefits of statins in populations.
Looking at Statistics
- An average person who has had a heart attack and takes statins for five years would add just over four days to their life expectancy.
- There's an assumption that mass prescription of statins has driven down death rates from heart disease, but the evidence suggests otherwise.
- In European countries high risk and low-risk people of heart disease over 12 years was there a difference in was there a reduction in heart disease death rates because of statins and the answer was no.
Stopping Statin Use
In this section, Dr. Aseem Malhotra talks about stopping statin use.
Side Effects
- Real-world data tells us that even people who have had heart attacks may stop taking statins within a few years mainly because of side effects.
- About 50% of them will stop taking it.
- This hasn't had an impact on the population.
Reaction to Publication
In this section, Dr. Aseem Malhotra talks about the reaction to his publication on the benefits of statins.
Publication Reaction
- After his publication in bmj initially um and then he lost his job.
- The benefits of statins are marginal despite being one of the most powerful lucrative drugs in the history of medicine.
Working for Free in a Cardiology Department
In this section, Aseem discusses his experience working for free in a Cardiology Department and how he received an email from the editor of the British Medical Journal.
Email from the Editor of the British Medical Journal
- Aseem received an email from the editor of the British Medical Journal asking to meet with him.
- The editor informed Aseem about Professor Rory Collins, who is considered one of the world's leading Statin researchers at Oxford University.
- Professor Rory Collins had requested that Abramson and Malhotra's papers be retracted due to significant errors on the side effect issue.
Back and Forth with BMJ
- The BMJ refused to retract Abramson and Malhotra's papers but offered to publish a critique if Aseem wanted to send one.
- However, Professor Rory Collins decided not to do so and instead went to The Guardian newspaper with his concerns.
- This caused a lot of backlash as people were concerned that it would cause harm since patients would stop taking their statins.
Potential Career Destruction
In this section, Aseem talks about how he was essentially on trial for two months due to potential career destruction after articles were sent for independent review by BMJ.
Independent Review by BMJ
- Articles were sent for independent review by BMJ which could have potentially destroyed Aseem's career if they were retracted.
- The panel convened and asked Aseem to send in responses before coming back 6-0 unanimous in favor of not retracting his article.
Continuing Campaign
- After this experience, Aseem continued his campaign on ethical evidence-based medical practice and published other journals.
- He talked about transparent communication, ethical evidence-based medicine, and the prescription of statins.
- Aseem also discussed how focusing on lifestyle changes such as low carb Mediterranean diet and exercise could be more powerful than just giving people pills.
Backlash
In this section, Aseem talks about the backlash he faced during his campaign.
Thick Skin
- Aseem realized that as a public health advocate, he needed to have a thick skin and grow a rhinoceroside due to the backlash he faced.
- There was smearing going on but Aseem continued his campaign for ethical evidence-based medical practice.
Interesting Journey
- The journey was interesting as there were many challenges along the way.
- However, Aseem continued to push forward with his campaign despite the potential career destruction and backlash he faced.
The Importance of Truth and Transparency in Medicine
In this section, the speaker talks about how speaking out against corruption and conflicts of interest in medicine can lead to attacks, but it is important to stand up for truth and transparency.
Standing Up Against Industry Threats
- When your work threatens an industry or an ideological cabal, you will be attacked.
- Other doctors came out to support the speaker when they spoke out against corruption and conflicts of interest in medicine.
- The speaker believes that there are biases and conflicts of interest in the research on statins coming from a department at Oxford that has taken over 200 million pounds from the drug industry.
- The data from the department was kept commercially confidential, making it impossible for anyone to independently verify the data.
Conflicts of Interest Limiting Judgment
- Professor Collins' judgment may be clouded by his conflict of interest as his department has received funding from the drug industry for research on statins.
- The speaker believes that Professor Collins' lack of clinical experience limits his ability to properly evaluate evidence.
Turn any video into a summary like this
YouTube links, meetings, lectures. With transcripts, search, and chat.